Ind-Swift (INDSWFTLAB) | Stock Overview & Key Data
Ind-Swift Performance Comparison
Stock Range
Today's Range
52 Week Range
All-Time High: ₹296.50 on December 20, 2004
Explore how other Indian stocks compare to their 52-week ranges: View IN Market 52-Week Insights
Key Statistics
Join Our India Telegram Channel
Get Instant Market Updates: 52-Week High/Low Alerts, Breakout Notifications & Expert Stock Analysis Delivered To Your Phone. Join Traders Making Informed Decisions Daily!
Financial Highlights
Quarter Income Flow
Mar 31, 2025
Annual Income Flow
2025
Peer Performance Comparison
| Company | Market Cap | 1W | 1M | 3M | 6M | YTD | 1Y | 3Y | 5Y | 10Y | 15Y | 20Y |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
|
Ind-Swift
INDSWFTLAB
|
11.98B Small-cap | 3.25% | 20.88% | 18.01% | 65.79% | 78.85% | 50.16% | 121.21% | 39.40% | 310.65% | 68.51% | 158.37% |
|
Sun Pharmaceutical
SUNPHARMA
|
3.88T Large-cap | 0.96% | -3.84% | 1.28% | 0.50% | 4.93% | 7.10% | 82.23% | 170.41% | 143.23% | 656.74% | 2,541.29% |
|
Divi's Laboratories
DIVISLAB
|
1.69T Large-cap | 1.34% | -2.25% | 8.85% | 4.11% | 4.17% | -0.43% | 85.44% | 58.15% | 496.33% | 1,610.60% | 10,946.76% |
|
Sun Pharma Advanced
SPARC
|
46.75B Small-cap | 12.49% | 39.95% | 100.62% | 67.89% | 69.61% | 34.88% | 14.54% | -3.55% | -20.47% | 148.26% | -23.02% |
|
Innova Captab
INNOVACAP
|
41.43B Small-cap | 8.95% | 10.45% | 34.08% | 34.58% | 28.37% | 3.87% | 74.08% | 74.08% | 74.08% | 74.08% | 74.08% |
|
Gujarat Themis
GUJTHEM
|
35.41B Small-cap | -4.89% | 4.00% | 38.98% | -1.40% | -12.59% | 15.75% | 76.92% | 76.92% | 76.92% | 76.92% | 76.92% |
Ownership & Short Interest
Calculate Your Ind-Swift Investment Returns
Long-Term Investment Performance Analysis
Ind-Swift stock price in Aug 2016 was ₹37.95, A ₹1,000.00 lump sum investment in Ind-Swift made 9 years ago would be worth approximately ₹4,264.56 today, representing a exceptional return of 326.46%. This translates to an annualized return (CAGR) of 15.83%.
9 Years 10 Months Investment Scenario (Aug 2016 - Jun 2026)
Investment Breakdown
Value Comparison
Disclaimer: This calculator is for informational purposes only and does not consider taxes, fees, or other costs associated with investing. Past performance does not guarantee future results.
Frequently Asked Questions
- What is INDSWFTLAB's 52-week high and low?
- In the last 52 weeks, Ind-Swift reached a high of ₹173.25 (on June 1, 2026) and a low of ₹87.15 (on December 31, 2025).
- What is the market cap and P/E ratio for INDSWFTLAB?
- Curious about Ind-Swift's size and valuation? Its market capitalization stands at 11.98B. When it comes to valuation, the P/E ratio (trailing twelve months) is 4.00, and the forward P/E (looking ahead) is N/A.
- Does INDSWFTLAB pay dividends? If so, what's the yield?
- As for dividends, Ind-Swift isn't currently offering a significant yield, or that specific data isn't available right now.
- Who are Ind-Swift's main competitors or similar companies to consider before investing?
When looking at Ind-Swift, it can be helpful to see how it compares to other players in its field. Here are a few similar companies or key competitors:
Company Mkt Cap Sector Industry 1Y Return 3Y Return Sun Pharmaceutical
SUNPHARMA3.88T Healthcare Drug Manufacturers - Specialty & Generic 7.10% 82.23% Divi's Laboratories
DIVISLAB1.69T Healthcare Drug Manufacturers - Specialty & Generic -0.43% 85.44% Sun Pharma Advanced
SPARC46.75B Healthcare Drug Manufacturers - Specialty & Generic 34.88% 14.54% Innova Captab
INNOVACAP41.43B Healthcare Drug Manufacturers - Specialty & Generic 3.87% 74.08% Gujarat Themis
GUJTHEM35.41B Healthcare Drug Manufacturers - Specialty & Generic 15.75% 76.92% For a more comprehensive list, please see the Peer Performance Comparison table on this page.
- What are the key financial health indicators for Ind-Swift Laboratories Ltd.? (e.g., ROE, Debt/Equity)
- To get a sense of Ind-Swift's financial health, here are a few key indicators: its Return on Equity (ROE) over the last twelve months is 21.35%, the Debt to Equity ratio from the most recent quarter is 1.69, and its Gross Profit Margin stands at 53.44%.
- What is the recent revenue and earnings growth for INDSWFTLAB?
- Looking at Ind-Swift's growth, its revenue over the trailing twelve months (TTM) was INR6B. Compared to the same quarter last year (YoY), quarterly revenue grew by 1,641.10%, and quarterly earnings saw a YoY growth of 153,743.50%.
- How much of INDSWFTLAB stock is held by insiders and institutions?
- Wondering who owns Ind-Swift stock? Company insiders (like executives and directors) hold about 66.37% of the shares, while institutional investors (such as mutual funds and pension funds) own approximately 4.62%.
For more common questions about our data, please visit our About Data page.
Data is provided for informational purposes only. Devyara does not guarantee the accuracy of the data displayed.